Pittenger & Anderson Inc’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $14.9M | Sell |
67,557
-3,753
| -5% | -$1.04M | 0.53% | 59 |
|
|
2026
Q1 | $21.1M | Buy |
71,310
+608
| +0.9% | +$181K | 0.84% | 41 |
|
|
2025
Q4 | $19.3M | Buy |
70,702
+2,123
| +3% | +$577K | 0.74% | 43 |
|
|
2025
Q3 | $18.5M | Buy |
68,579
+1,025
| +2% | +$279K | 0.68% | 42 |
|
|
2025
Q2 | $18.6M | Buy |
67,554
+1,511
| +2% | +$411K | 0.68% | 41 |
|
|
2025
Q1 | $17.5M | Sell |
66,043
-19
| -0% | -$4.69K | 0.64% | 41 |
|
|
2024
Q4 | $15.3M | Buy |
66,062
+482
| +0.7% | +$111K | 0.56% | 47 |
|
|
2024
Q3 | $14.5M | Sell |
65,580
-1,089
| -2% | -$225K | 0.54% | 49 |
|
|
2024
Q2 | $13.1M | Sell |
66,669
-1,765
| -3% | -$365K | 0.54% | 54 |
|
|
2024
Q1 | $14.7M | Buy |
68,434
+1,180
| +2% | +$248K | 0.6% | 48 |
|
|
2023
Q4 | $14.2M | Buy |
67,254
+359
| +0.5% | +$76.6K | 0.63% | 46 |
|
|
2023
Q3 | $13.4M | Sell |
66,895
-1,109
| -2% | -$220K | 0.68% | 43 |
|
|
2023
Q2 | $12.6M | Buy |
68,004
+293
| +0.4% | +$54.1K | 0.61% | 51 |
|
|
2023
Q1 | $13M | Buy |
67,711
+1,729
| +3% | +$313K | 0.67% | 45 |
|
|
2022
Q4 | $11.1M | Buy |
65,982
+15,103
| +30% | +$2.62M | 0.61% | 52 |
|
|
2022
Q3 | $9.01M | Sell |
50,879
-509
| -1% | -$101K | 0.54% | 58 |
|
|
2022
Q2 | $10.5M | Buy |
51,388
+1,128
| +2% | +$239K | 0.61% | 52 |
|
|
2022
Q1 | $12M | Buy |
50,260
+3,701
| +8% | +$869K | 0.59% | 56 |
|
|
2021
Q4 | $10.6M | Buy |
46,559
+966
| +2% | +$213K | 0.49% | 62 |
|
|
2021
Q3 | $8.82M | Buy |
45,593
+1,469
| +3% | +$298K | 0.44% | 69 |
|
|
2021
Q2 | $9.38M | Buy |
44,124
+219
| +0.5% | +$46.2K | 0.48% | 64 |
|
|
2021
Q1 | $8.97M | Sell |
43,905
-25,177
| -36% | -$4.96M | 0.48% | 63 |
|
|
2020
Q4 | $12.6M | Buy |
69,082
+3,476
| +5% | +$591K | 0.71% | 34 |
|
|
2020
Q3 | $11M | Buy |
65,606
+3,122
| +5% | +$526K | 0.7% | 37 |
|
|
2020
Q2 | $10.2M | Buy |
62,484
+2,080
| +3% | +$373K | 0.71% | 33 |
|
|
2020
Q1 | $10.4M | Sell |
60,404
-276
| -0.5% | -$54.9K | 0.89% | 25 |
|
|
2019
Q4 | $12.2M | Buy |
60,680
+346
| +0.6% | +$71K | 0.81% | 24 |
|
|
2019
Q3 | $12.8M | Sell |
60,334
-285
| -0.5% | -$59.5K | 0.92% | 22 |
|
|
2019
Q2 | $11.8M | Sell |
60,619
-1,124
| -2% | -$207K | 0.88% | 23 |
|
|
2019
Q1 | $10.2M | Buy |
61,743
+455
| +0.7% | +$80.4K | 0.79% | 28 |
|
|
2018
Q4 | $11.5M | Sell |
61,288
-108
| -0.2% | -$19.9K | 1.06% | 15 |
|
|
2018
Q3 | $10.4M | Buy |
61,396
+790
| +1% | +$133K | 0.82% | 22 |
|
|
2018
Q2 | $9.94M | Sell |
60,606
-305
| -0.5% | -$49.8K | 0.85% | 21 |
|
|
2018
Q1 | $9.85M | Buy |
60,911
+865
| +1% | +$138K | 0.86% | 21 |
|
|
2017
Q4 | $8.77M | Buy |
60,046
+1,116
| +2% | +$159K | 0.77% | 26 |
|
|
2017
Q3 | $8M | Buy |
58,930
+2,175
| +4% | +$275K | 0.73% | 27 |
|
|
2017
Q2 | $7.11M | Buy |
56,755
+12,360
| +28% | +$1.48M | 0.68% | 29 |
|
|
2017
Q1 | $5.27M | Buy |
44,395
+3,640
| +9% | +$438K | 0.53% | 49 |
|
|
2016
Q4 | $4.7M | Buy |
40,755
+22,415
| +122% | +$2.49M | 0.5% | 52 |
|
|
2016
Q3 | $1.92M | Buy |
18,340
+17,765
| +3,090% | +$1.85M | 0.21% | 121 |
|
|
2016
Q2 | $56K | Hold |
575
| – | – | 0.01% | 262 |
|
|
2016
Q1 | $55K | Hold |
575
| – | – | 0.01% | 287 |
|
|
2015
Q4 | $52K | Sell |
575
-395
| -41% | -$37.2K | 0.01% | 300 |
|
|
2015
Q3 | $90K | Sell |
970
-390
| -29% | -$37.1K | 0.01% | 280 |
|
|
2015
Q2 | $127K | Sell |
1,360
-745
| -35% | -$69.5K | 0.02% | 273 |
|
|
2015
Q1 | $199K | Sell |
2,105
-130
| -6% | -$12K | 0.03% | 253 |
|
|
2014
Q4 | $198K | Buy |
+2,235
| New | +$189K | 0.03% | 244 |
|
Other funds holding CME
Pittenger & Anderson Inc's CME Position: Q2 2026 in Review
Pittenger & Anderson Inc reduced its CME Group (CME) stake by 5.3% in Q2 2026, selling an estimated $1.04M and leaving 67,557 shares worth $14.9M. The position accounts for 0.53% of the portfolio, ranked #59.
Pittenger & Anderson Inc first reported a position in CME in Q4 2014 and has held it in 47 quarters since. The position peaked at $21.1M in Q1 2026. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Pittenger & Anderson Inc held 67,557 shares of CME Group worth $14.9M as of Q2 2026.
- Pittenger & Anderson Inc sold 3,753 CME Group shares in Q2 2026, an estimated $1.04M.
- CME Group made up 0.53% of Pittenger & Anderson Inc's portfolio in Q2 2026, its #59 holding.
- Pittenger & Anderson Inc first reported a position in CME Group in Q4 2014 and has held it in 47 quarters since.
- Pittenger & Anderson Inc's CME Group position peaked at $21.1M in Q1 2026.
- 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Pittenger & Anderson Inc's 13F filing for Q2 2026, filed 27 Jul 2026.